| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 11/18/2014 | US8889136 Multiple-variable dose regimen for treating TNFα-related disorders |
| 11/18/2014 | US8889135 Methods of administering anti-TNFα antibodies |
| 11/18/2014 | US8889134 Modulators of Candida hyphal morphogenesis and uses thereof |
| 11/18/2014 | US8889133 Methods of treating diabetes with Dll4 antagonists |
| 11/18/2014 | US8889132 Antibodies against human HIF-1α |
| 11/18/2014 | US8889131 NOTCH inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof |
| 11/18/2014 | US8889130 Treatment of osteoarthritis and pain |
| 11/13/2014 | US20140336365 Cdr regions of monoclonal antibody that antagonize sphinogosine 1-phosphate and related methods |
| 11/13/2014 | US20140336364 Monoclonal antibody against interferon-gamma (ifn-gamma) inducing factor (ifig, il-18) |
| 11/13/2014 | US20140336363 Antibodies against human csf-1r and uses thereof |
| 11/13/2014 | US20140336362 Avian Derived Antibodies |
| 11/13/2014 | US20140336361 Assembly of bispecific antibodies |
| 11/13/2014 | US20140336360 Tyrosine, Serine and Threonine Phosphorylation Sites |
| 11/13/2014 | US20140336236 Novel alk and ntrk1 fusion molecules and uses thereof |
| 11/13/2014 | US20140336156 Antibodies to 25-hydroxyvitamin d2 and d3 and uses thereof |
| 11/13/2014 | US20140335628 Method of obtaining a binder to prepro-vasopressin or fragments thereof |
| 11/13/2014 | US20140335609 Protein expression from multiple nucleic acids |
| 11/13/2014 | US20140335565 Method for production of polypeptide |
| 11/13/2014 | US20140335564 Il-17 binding proteins |
| 11/13/2014 | US20140335563 Stabilized human igg2 and igg3 antibodies |
| 11/13/2014 | US20140335538 Methods of diagnosing als |
| 11/13/2014 | US20140335127 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 11/13/2014 | US20140335126 V1v2 immunogens |
| 11/13/2014 | US20140335119 POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL |
| 11/13/2014 | US20140335107 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 11/13/2014 | US20140335103 Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof |
| 11/13/2014 | US20140335102 In silico affinity maturation |
| 11/13/2014 | US20140335101 Nanobodies against tumor necrosis factor-alpha |
| 11/13/2014 | US20140335099 Therapeutic human anti-il-1r1 monoclonal antibody |
| 11/13/2014 | US20140335098 Method of isolating human antibodies |
| 11/13/2014 | US20140335097 Expression vector |
| 11/13/2014 | US20140335096 Anti-glucagon antibodies and uses thereof |
| 11/13/2014 | US20140335095 Compositions and methods related to protein a (spa) antibodies as an enhancer of immune response |
| 11/13/2014 | US20140335094 Mammalian cytokines; related reagents and methods |
| 11/13/2014 | US20140335093 PD-1 Antibodies and PD-L1 Antibodies and Uses Thereof |
| 11/13/2014 | US20140335092 Compositions and methods for immunization against drug resistant acinetobacter baumannii |
| 11/13/2014 | US20140335091 Anti-glucagon receptor antibodies and methods of use thereof |
| 11/13/2014 | US20140335090 Therapeutic agent for cancer, and method for determining prognosis of cancer |
| 11/13/2014 | US20140335089 Antigen-binding molecule for promoting elimination of antigens |
| 11/13/2014 | US20140335088 Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders |
| 11/13/2014 | US20140335087 Aspartyl-trna synthetase-fc conjugates |
| 11/13/2014 | US20140335085 Fusion protein |
| 11/13/2014 | US20140335084 Antibody formulation |
| 11/13/2014 | US20140335081 Treatment For Rheumatoid Arthritis |
| 11/13/2014 | US20140335078 Use Of Complement Inhibitors To Treat Ocular Diseases |
| 11/13/2014 | US20140335077 Compositions and Methods for the Treatment of Cancer Using IGF-IR Antagonists and MAPK/ERK Inhibitors |
| 11/13/2014 | US20140335076 Humanized Monoclonal Antibodies to Hepatocyte Growth Factor |
| 11/13/2014 | US20140335075 Immunoglobulin constant region fc receptor binding agents |
| 11/13/2014 | US20140335071 Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV |
| 11/13/2014 | US20140335053 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 11/13/2014 | US20140335023 Plasma kallikrein binding proteins |
| 11/13/2014 | US20140335022 Method for patient selection |
| 11/13/2014 | US20140335016 Bacteriophage Gene 3 Protein Compositions and Use as Amyloid Binding Agents |
| 11/13/2014 | US20140335014 Il-1 alpha dual variable domain immunoglobulins and uses thereof |
| 11/11/2014 | US8884214 Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry |
| 11/11/2014 | US8884096 Method for the production of antibodies |
| 11/11/2014 | US8883992 Humanized anti-CD19 antibodies |
| 11/11/2014 | US8883985 Antibody-immobilized carrier, method of producing antibody-immobilized carrier, and use of said antibody-immobilized carrier |
| 11/11/2014 | US8883984 Human monoclonal antibodies to CTLA-4 |
| 11/11/2014 | US8883983 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 11/11/2014 | US8883982 Compositions and methods for increasing serum half-life |
| 11/11/2014 | US8883981 Recombinant antibody composition |
| 11/11/2014 | US8883980 Antigen binding molecules with increased Fc receptor binding affinity and effector function |
| 11/11/2014 | US8883979 Anti-prolactin receptor antibody formulations |
| 11/11/2014 | US8883978 Antibodies to tumor endothelial marker 7R |
| 11/11/2014 | US8883977 MUC1 antibody |
| 11/11/2014 | US8883976 Antibodies against human tweak and uses thereof |
| 11/11/2014 | US8883975 Antibodies against IL-18R1 and uses thereof |
| 11/11/2014 | US8883974 Device for enhancing immunostimulatory capabilities of T-cells |
| 11/11/2014 | US8883973 Fc variants with altered binding to FcRn |
| 11/11/2014 | US8883972 High specificity monoclonal antibody against a protein or a polypeptide having oxidative modification |
| 11/11/2014 | US8883966 RAB6KIFL/KIF20A epitope peptide and vaccines containing the same |
| 11/11/2014 | US8883962 Zinc-responsive peptides, and methods of use thereof |
| 11/11/2014 | US8883736 Compositions and methods for treating and diagnosing cancer |
| 11/11/2014 | US8883735 Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs |
| 11/11/2014 | US8883724 Active antiangiogenic therapy |
| 11/11/2014 | US8883692 Method for cell surface displaying of target proteins using Bacillus anthracis exosporium |
| 11/11/2014 | US8883480 Antiviral peptide against avian influenza virus H9N2 |
| 11/11/2014 | US8883447 Anti-GLP-1R antibodies and their uses |
| 11/11/2014 | US8883429 Viral diagnostics |
| 11/11/2014 | US8883428 Methods to determine atherosclerosis regression, plaque stabilization and cardiovascular risk |
| 11/11/2014 | US8883162 Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors |
| 11/11/2014 | US8883161 Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant |
| 11/11/2014 | US8883160 Dock-and-lock (DNL) complexes for therapeutic and diagnostic use |
| 11/11/2014 | US8883159 Antibodies against CDCP1 for the treatment of cancer |
| 11/11/2014 | US8883158 Compositions and methods for antibodies targeting complement protein C5 |
| 11/11/2014 | US8883157 Targeting rare human PCSK9 variants for cholesterol treatment |
| 11/11/2014 | US8883156 Purified antibody composition |
| 11/11/2014 | US8883155 Methods for treating hematopoietic malignancies |
| 11/11/2014 | US8883154 Antibody-mediated modulation of allergy |
| 11/11/2014 | US8883153 Methods for preventing and treating angioedema |
| 11/11/2014 | US8883152 Anti-cobra toxin antibody fragments and method of producing a VH H library |
| 11/11/2014 | US8883151 IL-17 receptor antibody formulation |
| 11/11/2014 | US8883150 Soluble “heavy-chain only” antibodies |
| 11/11/2014 | US8883149 Antibody combinations and use of same for treating cancer |
| 11/11/2014 | US8883147 Immunoglobulins insertions, deletions, and substitutions |
| 11/11/2014 | US8883146 Protein formulations and methods of making same |
| 11/11/2014 | US8883145 Methods of treatment with DLL4 antagonists and an anti-hypertensive agent |
| 11/11/2014 | US8883134 Human interleukin-1 receptor antagonist—hybrid Fc fusion protein |
| 11/06/2014 | US20140331366 Influenza hemagglutinin antibodies, compositions and related methods |